Access to the right medicines is an important component in managing arthritis. In Canada, the Patented Medicines Prices Review Board (PMPRB) plays a key role in drug pricing in Canada. On July 1, 2020, the newly amended Patented Medicines Regulations will come into...
In July 2019, Health Canada began a 60-day consultation on the draft guidance: The Distinction Between Promotional and Non-promotional Messages and Activities for Health Products, formerly known as a policy entitled The Distinction Between Advertising and Other...
Français du Canada 
English